![Female scientist working in the CDC laboratory.](https://media.venturecapitaljournal.com/uploads/2020/03/Coronavirus-GettyImages-1208595556.jpg)
Here’s what VC-backed biotechs should focus on amid covid-19
Tom Walker of Rev1 Ventures addresses the question of whether investors should back biotech start-ups that focus on the coronavirus and other potential pandemics. Here's what you should know.